NEW YORK (GenomeWeb News) – Standard & Poor’s last night said that Life Technologies, the name of the combined Invitrogen and Applied Biosystems, will replace Applied Biosystems in the S&P 500 Index.
Invitrogen and ABI expect to close their $6.7 billion merger later this week, after which time they will operate under the Life Technologies name.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.